Season 2 Episode 2: As part of our Pharma15 Live! web series, we recently had the opportunity to sit down with three-time clinical trial participant Richard Brescia for a candid conversation about his experience – both positive and negative. As an industry, we can learn a tremendous amount by going directly to the heart of the matter and listening to the “patient voice.”
Topics: Patient Engagement, Patient, Pharma15
Patient engagement is important, but so is the engagement of doctors and medical personal delivering the protocol to the patient. Gerald Wayne Dryden, Jr., MD, PhD from the University of Louisville discusses patient engagement in a special edition of Pharma 15 Live! with fellow panelists Linda A. Glaser, MD, PhD from Coastal Biomedical Research, Inc. and Annie Finstein, a clinical trial participant.
Topics: Patient Engagement, Conferences, Site Engagement, Pharma15
What basic information and support might a patient need when considering a clinical trial? Clinical trial participant Annie Finstein shares her perspective alongside a panel of doctors at the CHI SCOPE Summit 2019 in this special edition of Pharma15 Live!
Joining Annie are guest panelists Gerald Wayne Dryden, Jr., MD, PhD, MSPH, M.Sc. from the University of Louisville, and Linda A. Glaser, MD, PhD from Coastal Biomedical Research, Inc.
Topics: Patient Engagement, Conferences, Site Engagement, Pharma15
BBK hosted its signature Pharma15 Live! debate series to the 10th Annual SCOPE Summit on February 19, 2019. Bonnie A. Brescia moderated a panel of doctors and patient during the conference’s plenary keynote program on the topic of “Do Engagement Tools Live Up to Their Hype?”
Topics: Patient Engagement, Conferences, Site Engagement, Pharma15
We are excited to introduce one of our dynamic keynote panelists, Linda A. Glaser, MD, PhD of Coastal Biomedical Research, Inc. in Santa Monica, CA.
Linda will be sharing her site voice and insights at BBK’s Pharma15 Live! debate series at the 10th Annual SCOPE Summit on Feb 19.
While pursuing a successful career in private practice, Linda’s passion for research lead her to establish Coastal Biomedical Research, Inc. in Santa Monica. The practice specializes in clinical trials across many therapies, from diabetes to hypertension to pain management. As Medical Director, she understands the patient experience and medical site needs. As a business owner, she also understands the importance of adaptability, efficiencies and overcoming operational challenges.
What is most rewarding to you as you consider your contribution to clinical trial research?
The ability to help advance science and treat disease.
How do you define patient engagement? What does that term mean to you?
Topics: Patient Retention, Patient Recruitment, Physician Engagement, Conferences, Site Engagement, clinical research, Patient Experience, Pharma15
BBK’s signature Pharma15 Live! web series is coming to the 10th Annual SCOPE Summit for Clinical Ops Executives. On February 19, Bonnie A. Brescia, BBK’s founding principal, will moderate a panel during the conference’s plenary keynote program on the topic of “Do Engagement Tools Live Up to Their Hype?”
We are pleased to introduce one of our panelists, Gerald Wayne Dryden, Jr., MD, PhD, MSPH, MSc of University of Louisville, Kentucky.
Dr. Gerald “Tad” Dryden is Professor of Medicine and Director of the Inflammatory Bowel Disease Program in the Division of Gastroenterology at the University of Louisville in Louisville, KY. He earned his MD at the University of Kentucky College of Medicine in Lexington, KY, and completed his internal medicine internship and residency at the Naval Medical Center in Portsmouth, VA. He then completed his gastroenterology fellowship at the Naval Medical Center in San Diego, CA. During his tenure at the University of Louisville, he earned a Master of Science in Public Health, a Master of Science in Microbiology and Immunology, and a PhD in Microbiology and Immunology. Dr. Dryden’s research interests include developing new therapies from botanical sources and new medical devices to improve endoscopic care.
What is most rewarding to you as you consider your contribution to clinical trial research?
It is very rewarding when I am involved with a drug from the ground up -- seeing research patients benefit from the drug, then eventually being able to prescribe it to my clinic patients.
Topics: Patient Retention, Patient Recruitment, Physician Referrals, Patient Engagement, Site Support, Patient, Patient Experience, Pharma15
So much of the focus of clinical trial participation is on the patient and reducing site staff burden. But sometimes we forget about the role of the caregiver. After all, it is usually the caregiver driving the patient to their appointments, managing medication schedules, taking notes at doctor’s appointments, and much more. It makes you wonder: who is the caregiver’s caregiver? Enter Zaggo, a non-profit organization that provides the tools caregivers need to take care of their loved one as effectively and efficiently as possible.
Zaggo was born out of the experience of its founder and president, Roberta Carson, after she was thrust into the role of caregiver for her son Zachary during his 27-month battle with pediatric brain cancer.
Topics: Patient Experience, Pharma15, Most Viewed
Pharma15 Live! jumped at the chance to hear SnapIoT’s Ed Triebell discuss his company’s ground-breaking product, a software platform which allows users to seamlessly connect any smart device to any mobile device—and to any cloud.
Topics: Disruptive Innovation, Conferences, clinical research, clinical trials, Pharma15, digital, provisional device, devices, BYOD
Pharma15 Live! simply could not resist speaking with Jae Chung, founder of the “Turbo Tax for clinical trials start-up,” goBalto - and his furry friend, the Siberian Husky puppy aptly named Balto. Chung discussed his company’s mission to automate the laborious manual processes related to clinical trial start-up.
Topics: Disruptive Innovation, Conferences, clinical research, clinical trials, Pharma15, digital, Puppies
Georgia Mitsi spoke with BBK Worldwide’s Aaron Fleishman about her company’s newest app E.V.A — an engagement platform for patients who suffer from chronic neurological conditions. Says Mitsi: “It’s about evaluate, validate and act.”
Topics: Disruptive Innovation, clinical research, clinical trials, Pharma15, Most Viewed, digital, provisional device, devices, BYOD